Efficacy of Neurolytic Celiac Plexus Block in Varying Locations of Pancreatic Cancer
- 1 February 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 92 (2) , 347
- https://doi.org/10.1097/00000542-200002000-00014
Abstract
Background: Neurolytic celiac plexus block (NCPB) is an effective way of treating severe pain in some patients with pancreatic malignancy. However, there are no studies to date that evaluate the effectiveness of NCPB related to the site of primary pancreas cancer. The aim of the study was to assess the effectiveness of NCPB in pancreatic cancer pain, depending on the location of the pancreatic tumor. Methods: The prospective study was conducted in 50 consecutive patients diagnosed with pancreatic cancer. The patients were categorized into two different groups depending on tumor localization: group 1: patients with the cancer of the head of the pancreas and group 2: patients with the cancer of the body and tail of the pancreas. The qualitative and quantitative pain analyses were performed before and after NCPB. The patients underwent prognostic celiac plexus block with bupivacaine, followed by neurolysis during fluoroscopic control within the next 24 h. Results: After NCPB, 37 patients (74%) had effective pain relief during the first 3 months or until death. Of the 37 patients who had effective pain relief, 33 (92%) were from group 1 and 4 (29%) were from group 2. In the remaining 13 patients (3 patients from group 1 and 10 patients from group 2), pain relief after NCPB was not satisfactory. Those patients were scheduled for repeated retrocrural neurolysis during computed tomography control. Computed tomography showed massive growth of the tumor around the celiac axis with metastases. After repeated neurolysis, pain relief clinically still was not satisfactory, necessitating additional opioid treatment. Conclusion: In this study, unilateral transcrural celiac plexus neurolysis has been shown to provide effective pain relief in 74% of patients with pancreatic cancer pain. Neurolysis was more effective in cases with tumor involving the head of the pancreas. In the cases with advanced tumor proliferation, regardless of the technique used, the analgesic effects of NCPB were not satisfactory.Keywords
This publication has 16 references indexed in Scilit:
- Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer painPain, 1996
- Neurolytic Celiac Plexus Block for Treatment of Cancer PainAnesthesia & Analgesia, 1995
- Chemical Splanchnicectomy in Patients with Unresectable Pancreatic Cancer A Prospective Randomized TrialAnnals of Surgery, 1993
- Celiac plexus block versus analgesics in pancreatic cancer painPain, 1993
- Pancreatic CarcinomaNew England Journal of Medicine, 1992
- Has the analgesic efficacy of neurolytic celiac plexus block been demonstrated in pancreatic cancer pain?Pain, 1990
- Pain management of pancreatic carcinoma: a reviewPain, 1989
- Coeliac plexus block for pain in pancreatic cancer and chronic pancreatitisBritish Journal of Surgery, 1983
- Abdominal Pain and Alcohol Celiac Plexus Nerve BlockAnesthesia & Analgesia, 1977
- Alcohol block of the celiac plexus for control of upper abdominal pain caused by cancer and pancreatitisJournal of Neurosurgery, 1971